Skip to main content
Elsevier
View Cart
Your Account

Books in Pharmacology general

BooksJournals

Targeting Enzymes in the Brain

  • 1st Edition
  • Volume 102
  • March 1, 2025
  • Takashi Tsukamoto
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 3 4 2 9 2 - 9
  • eBook
    9 7 8 - 0 - 4 4 3 - 3 4 2 9 3 - 6
Targeting Enzymes in the Brain series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Pharmacovigilance

  • 2nd Edition
  • February 28, 2025
  • Thao Doan + 4 more
  • English
Written by multidisciplinary experts in the fields of pharmaceutical and patient safety, Pharmacovigilance: A Practical Approach, 2nd Edition, provides a succinct, easy-to-digest overview of an increasingly critical area of medical safety. From cover to cover, this concise resource offers essential information for physicians and other health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.

PROTAC and similar technologies

  • 1st Edition
  • Volume 63
  • November 16, 2024
  • Radim Nencka
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 9 5 8 4 - 3
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 9 5 8 5 - 0
Annual Reports on Medicinal Chemistry: PROTAC and similar technologies Volume 63 in this series Annual Reports on Medicinal Chemistry, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors.

Emerging Therapeutic Targets and Drug Delivery Approaches in IBD

  • 1st Edition
  • Volume 101
  • November 12, 2024
  • Florin Selaru
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 3 1 3 5 8 - 5
  • eBook
    9 7 8 - 0 - 4 4 3 - 3 1 3 5 9 - 2
Emerging Therapeutic Targets and Drug Delivery Approaches in IBD, Volume 101 in this ongoing series, highlights new advances, with this volume presenting interesting chapters on timely topics, including Fibrosis in IBD – AXL as a Promising Therapeutic Target, Developing a pathway to test anti-fibrotic drugs in Crohn’s disease, Emerging therapeutics for the management of intestinal fibrosis and strictures, GCPII for IBD, Fistulas/stem cell products for IBD/Crohn’s, The landscape of new therapeutic opportunities for IBD, TL1A : A Model For The Use Of Precision Medicine For The Treatment of Crohn’s Disease and Ulcerative Colitis, Dectin-1 as a therapeutic target for IBD, and more.Additional sections cover BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases, Scripps - S1P, The potential of targeting TREM-1 in Inflammatory Bowel Disease, and Microbiome therapies.

Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19

  • 1st Edition
  • November 6, 2024
  • Nabeelah Bibi Sadeer + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 1 8 7 5 7 - 5
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 8 7 5 8 - 2
Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19: A Promising Response to the Global Unprecedented Pandemic presents comprehensive coverage of the pharmacological effects of natural products on the prevention and treatment of COVID-19. Sections provide traditional medicine approaches and their potential to prevent and treat COVID-19 infection, including traditional Chinese, Ayurvedic, Persian, and Kampo medicine, alongside an overview of nutritional regimens and their therapeutic potential. Other sections cover natural molecules such as flavonoids, saponins, coumarins, alkaloids, terpenes, polysaccharides, and several microbial natural products of relevant action against viruses. Final chapters cover nanotherapeutic approaches.This is a valuable resource for researchers and academics in the fields of herbal medicine, pharmacology, pharmacognosy and for professionals in the pharmaceutical industries and anyone interested in natural products and their application for therapeutic purposes.

Annual Reports in Medicinal Chemistry: Roadmaps

  • 1st Edition
  • Volume 62
  • October 30, 2024
  • Katherine Seley-Radtke
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 9 6 1 0 - 9
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 9 6 1 1 - 6
Annual Reports in Medicinal Chemistry: Roadmaps, Volume 62 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. This release provides a compendium of information on newly approved drugs and compounds entering late-stage clinical trials, making it a valuable resource for graduate students pursuing research in medicinal chemistry

Human Microbiome Drug Targets

  • 1st Edition
  • October 23, 2024
  • Genevieve Dable-Tupas + 3 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 1 5 4 3 5 - 5
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 5 4 3 6 - 2
Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease, the book's chapters discuss the role of the human microbiome in the pathophysiologic understanding of relevant diseases or disorders and their management. As changes in the human microbiome can provide clues to the probable cause and effect of diseases or disorders, as well as the impacts of therapy or intervention, this book is a welcomed addition to the existing research.Explaining how a better understanding of the microbiome and its impact on health and disease can pave the way for future discoveries leading to better health outcomes, this book will be of interest to drug developers, medicinal chemists, microbiologists, infectious disease specialists, biochemists, and students.

Progress in Medicinal Chemistry

  • 1st Edition
  • Volume 63
  • October 4, 2024
  • Jonathan Bentley + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 9 7 8 0 - 9
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 9 7 8 1 - 6
Progress in Medicinal Chemistry, Volume 63 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Specific chapters in this release include Harnessing conformational drivers in drug design, Recent Advances in the Medicinal Chemistry of Heterobifunctional Derivatives for Protein Homeostasis, and A Decade of Antimalarial Drug Discovery: New Targets, Tools and Molecules.

25 Pharma-Podcasts

  • 1st Edition
  • September 17, 2024
  • Adolfo Cavalié + 1 more
  • English
Pharma für die Ohren - Lernen, wo du gehst und stehst Augen müde, Kopf dick, Lernakku leer?Gönne deinen bildschirm-gequälten Augen eine Pause, ab auf’s Sofa oder in die Badewanne. Füße hoch, Pharma Audios auf die Ohren und lerne lauschend: In diesen Audios fassen wir die 25 am häufigsten verschriebenen Arzneistoffe kurz und knapp für dich zusammen.Die Gliederung folgt einem einheitlichen Schema, das erleichtert das Erfassen und Einprägen des Stoffs: Definition, Wirkprofil, Indikationen, Kontraindikationen, Unerwünschte Arzneimittelwirkungen (UAW), Pharmakokinetik/Medikamenteninteraktionen, weitere Bemerkungen.Ein Audio dauert 8-10 Minuten und bringt dich im Nu auf den Stand der wichtigsten Eigenschaften eines Arzneistoffs.Perfekt zum Wiederholen und VertiefenIdeal für die Vorbereitung auf Klausur und PrüfungZu jedem Audio gibt es eine schriftliche Zusammenfassung – die ideale LernkarteMit den Pharma-Audios wird das Lernen abwechslungsreich: Du lernst leichter, bleibst konzentriert, der Lernakku hält länger durch, das Wissen bleibt besser haften.So macht sogar Pharma-Lernen Spaß.

Quality Assurance Management

  • 1st Edition
  • July 20, 2024
  • Gayathri De Lanerolle + 3 more
  • English
  • eBook
    9 7 8 - 0 - 1 2 - 8 2 2 7 3 3 - 6
Quality Assurance Management: A Comprehensive Overview of Real-World Applications for High Risk Specialties demonstrates how to best design and implement standard operating procedures (SOPs) to ensure protocol and regulation adherence. The book showcases similarities and differences between healthcare and academic quality assurance systems, resulting in counter-productivity and performance issues, in addition to regulatory inspection preparedness. It uses the processes and standards of the UK to demonstrate how to combine QA and research building into ‘building blocks’ that share a common pathway for effective project design, analysis and unbiased interpretation of collated data.This book fills a gap, providing original research in QA that especially focuses on specialist areas. It will be of use to research and clinical staff working in clinical research within healthcare, academia and industry.

Related subjects

Pharmacology